Alembic Pharmaceuticals receives USFDA approval for Ticagrelor Tablets, 60 mg
Approval aligns Ticagrelor 60 mg with its reference drug Brilinta; estimated market size at US$ 236 million
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
USFDA approval
Alembic Pharmaceuticals secures USFDA approval for Triamcinolone Acetonide Injectable Suspension
Alembic Pharmaceuticals highlights expansion of its US portfolio with new injectable therapy approval
Alembic Pharmaceuticals receive USFDA approval for Divalproex Sodium capsules
Approval marks Alembic’s 193rd final ANDA approval in the United States market
Alembic Pharmaceuticals receives U.S. FDA approval for Paliperidone extended-release tablets
Approval covers Paliperidone tablets for the treatment of schizophrenia and schizoaffective disorder
Lupin receives approval from U.S. FDA for Topiramate Extended-Release Capsules
The company to market a generic equivalent of Trokendi XR Extended-Release Capsules
Tris Pharma receives USFDA approval for ONYDA XR, a liquid non-stimulant ADHD medication
ONYDA XR is indicated for the treatment of ADHD as monotherapy or as adjunctive therapy to approved CNS stimulant medications in…
Bristol Myers Squibb’s cell therapy gets USFDA nod for relapsed or refractory follicular lymphoma
95.7 per cent of patients responded to Breyanzi in the TRANSCEND FL trial
Gland Pharma receives USFDA approval for Edaravone Injection
The product is used to treat amyotrophic lateral sclerosis (ALS)
Penbraya approval sparks shift to pentavalent meningococcal vaccines in US: GlobalData
GSK is also in the process of developing a pentavalent vaccine, and positive Phase III data were announced earlier this year.…
USFDA approves Prasugrel tablets by Lupin
The product will be manufactured at Lupin’s facility in Goa